Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Thalidomide
Drug ID BADD_D02192
Description A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppresive and anti-angiogenic activity. It inhibits release of tumor necrosis factor-alpha from monocytes, and modulates other cytokine action. [PubChem]
Indications and Usage For the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). Also for use as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.
Marketing Status Prescription
ATC Code L04AX02
DrugBank ID DB01041
KEGG ID D00754
MeSH ID D013792
PubChem ID 5426
TTD Drug ID D0U7GK
NDC Product Code 59572-205; 59572-210; 59572-220; 59572-215; 69988-0052; 63818-0424; 17337-0301; 68554-0011
Synonyms Thalidomide | Sedoval | Thalomid
Chemical Information
Molecular Formula C13H10N2O4
CAS Registry Number 50-35-1
SMILES C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Deep vein thrombosisThrombomodulinP07204T0858315235749; 7878634
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blood bilirubin increased13.03.01.008--
Blood calcium increased13.11.01.0030.001158%Not Available
Blood creatine increased13.13.01.001--Not Available
Blood creatinine decreased13.13.01.003--Not Available
Blood creatinine increased13.13.01.004--
Blood glucose increased13.02.02.002--Not Available
Blood iron decreased13.11.01.0060.001737%Not Available
Blood lactate dehydrogenase increased13.04.02.002--
Blood potassium increased13.11.01.0110.001158%Not Available
Blood pressure abnormal13.14.03.0010.002316%Not Available
Blood pressure increased13.14.03.005--Not Available
Blood sodium decreased13.11.01.0120.002316%Not Available
Blood urea increased13.13.01.006--Not Available
Blood uric acid increased13.02.04.001--Not Available
Body temperature increased13.15.01.001--Not Available
Bone disorder15.02.04.004--Not Available
Bone pain15.02.01.0010.003474%
Bradycardia02.03.02.0020.006948%Not Available
Brain herniation17.11.01.002; 12.01.10.0010.001158%Not Available
Breast cancer21.05.01.003; 16.10.01.001--Not Available
Bronchitis22.07.01.001; 11.01.09.0010.005790%
Bronchospasm22.03.01.004; 10.01.03.012--
Burning sensation08.01.09.029; 17.02.06.001--Not Available
C-reactive protein increased13.09.01.007--Not Available
Cardiac arrest02.03.04.001--
Cardiac failure02.05.01.0010.002417%
Cardiac failure congestive02.05.01.002--Not Available
Cardiac murmur13.14.01.0010.001158%Not Available
Cardio-respiratory arrest22.02.06.007; 02.03.04.002--Not Available
Cardiovascular disorder24.03.02.009; 02.01.01.0010.001812%Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 24 Pages